These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 24627195)
41. Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects. Zhang K; Chen X; Zhou J; Yang C; Zhang M; Chao M; Zhang L; Liang C Oncotarget; 2017 Jul; 8(27):45020-45029. PubMed ID: 28445160 [TBL] [Abstract][Full Text] [Related]
42. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613 [TBL] [Abstract][Full Text] [Related]
44. Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis. Aksoy D; Ateş Ö; Kurt S; Çevik B; Sümbül O J Investig Med; 2016 Aug; 64(6):1143-7. PubMed ID: 27174941 [TBL] [Abstract][Full Text] [Related]
45. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer. Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608 [TBL] [Abstract][Full Text] [Related]
46. Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma. Kim HN; Yu L; Kim NY; Lee IK; Kim YK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ Am J Hematol; 2010 Oct; 85(10):822-4. PubMed ID: 20734458 [TBL] [Abstract][Full Text] [Related]
47. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis. Gürkan A; Emingil G; Saygan BH; Atilla G; Cinarcik S; Köse T; Berdeli A Arch Oral Biol; 2008 Apr; 53(4):337-45. PubMed ID: 18155181 [TBL] [Abstract][Full Text] [Related]
48. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291 [TBL] [Abstract][Full Text] [Related]
49. The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population. Kouhkan F; Motovali-Bashi M; Hojati Z Cancer Invest; 2008 Oct; 26(8):836-42. PubMed ID: 18798060 [TBL] [Abstract][Full Text] [Related]
50. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer]. Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531 [TBL] [Abstract][Full Text] [Related]
51. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer. Dos Reis ST; Pontes J; Villanova FE; Borra PM; Antunes AA; Dall'oglio MF; Srougi M; Leite KR J Urol; 2009 May; 181(5):2320-5. PubMed ID: 19303106 [TBL] [Abstract][Full Text] [Related]
52. A single nucleotide polymorphism in the matrix metalloproteinase 2 promoter is closely associated with high risk of nasopharyngeal carcinoma in Cantonese from southern China. Shao JY; Cao Y; Miao XP; Huang MY; Deng L; Hao JJ; Liang XM; Hu LF; Ernberg I; Lin DX; Zeng YX Chin J Cancer; 2011 Sep; 30(9):620-6. PubMed ID: 21880183 [TBL] [Abstract][Full Text] [Related]
53. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302 [TBL] [Abstract][Full Text] [Related]
54. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311 [TBL] [Abstract][Full Text] [Related]
55. Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer. dos Reis ST; Villanova FE; Andrade PM; Pontes J; de Sousa-Canavez JM; Sañudo A; Antunes AA; Dall'oglio MF; Srougi M; Moreira Leite KR Urol Oncol; 2010; 28(6):624-7. PubMed ID: 19117773 [TBL] [Abstract][Full Text] [Related]
56. The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction. Alp E; Menevse S; Tulmac M; Yilmaz A; Yalcin R; Cengel A Genet Test Mol Biomarkers; 2011 Apr; 15(4):193-202. PubMed ID: 21142815 [TBL] [Abstract][Full Text] [Related]
57. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416 [TBL] [Abstract][Full Text] [Related]
58. MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease. Gai X; Zhang Z; Liang Y; Chen Z; Yang X; Hou J; Lan X; Zheng W; Hou J; Huang M Clin Chim Acta; 2010 May; 411(9-10):719-24. PubMed ID: 20138860 [TBL] [Abstract][Full Text] [Related]
59. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868 [TBL] [Abstract][Full Text] [Related]